Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Current Assets (2018 - 2025)

TransMedics has reported Current Assets over the past 8 years, most recently at $637.8 million for Q4 2025.

  • Quarterly results put Current Assets at $637.8 million for Q4 2025, up 28.27% from a year ago — trailing twelve months through Dec 2025 was $637.8 million (up 28.27% YoY), and the annual figure for FY2025 was $637.8 million, up 28.27%.
  • Current Assets for Q4 2025 was $637.8 million at TransMedics, up from $613.0 million in the prior quarter.
  • Over the last five years, Current Assets for TMDX hit a ceiling of $662.7 million in Q2 2023 and a floor of $95.1 million in Q2 2022.
  • Median Current Assets over the past 5 years was $490.4 million (2024), compared with a mean of $374.9 million.
  • Biggest five-year swings in Current Assets: decreased 29.57% in 2022 and later soared 596.7% in 2023.
  • TransMedics' Current Assets stood at $118.7 million in 2021, then skyrocketed by 112.54% to $252.3 million in 2022, then skyrocketed by 102.4% to $510.7 million in 2023, then dropped by 2.63% to $497.2 million in 2024, then rose by 28.27% to $637.8 million in 2025.
  • The last three reported values for Current Assets were $637.8 million (Q4 2025), $613.0 million (Q3 2025), and $558.1 million (Q2 2025) per Business Quant data.